Physician
Desai, Brena
Desai, Brena was paid $4.55M by Medicaid between Jan 2018 and Dec 2024, across 103 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 36% of everything it billed.
33Billing provider infoDESAI, BRENA
FLUSHING, NY 11355
FLUSHING, NY 11355
33aNPI1619929502assigned 05/17/2006
33bProvider typeEmergency Medicine Physician
28Total paid$4.55M
24GClaims191,452
24DCodes billed103
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Emergency Medicine Physician providers in New York
Rank by total paid#30 of 2,113
Median peer was paid$5K
This provider vs. median1,003×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,076 | $439K | |
| 2019 | 20,659 | $486K | |
| 2020 | 24,706 | $446K | |
| 2021 | 33,331 | $585K | |
| 2022 | 37,938 | $880K | |
| 2023 | 30,655 | $913K | |
| 2024incomplete | 26,087 | $803K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 36% | 20,814 | 18,476 | $1.63M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.8% | 4,182 | 3,883 | $446K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.1% | 5,170 | 5,151 | $414K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 8.4% | 15,941 | 15,512 | $384K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 8.3% | 5,473 | 5,380 | $379K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.8% | 3,067 | 3,058 | $266K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.8% | 2,705 | 2,631 | $127K |
| 92587 | 2.7% | 5,631 | 5,606 | $125K | |
| 99401 | 2.2% | 7,067 | 7,009 | $101K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.2% | 1,040 | 1,038 | $101K |
| 90461 | 2.1% | 5,137 | 5,004 | $97K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.7% | 7,771 | 7,235 | $77K |
91 more codes
| 90670 | 1.0% | 2,545 | $46K | |
| 99460 | <1% | 588 | $38K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 505 | $27K |
| 92552 | <1% | 792 | $26K | |
| 97802 | <1% | 6,803 | $24K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 774 | $21K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,251 | $20K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 967 | $16K |
| 81002 | <1% | 5,577 | $13K | |
| 85013 | <1% | 3,269 | $12K | |
| 85018 | <1% | 6,213 | $11K | |
| 0071A | <1% | 292 | $11K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 980 | $10K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 757 | $10K |
| 99429 | <1% | 1,155 | $10K | |
| 0072A | <1% | 256 | $10K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 414 | $9K |
| H0001 | Alcohol and/or drug assessment | <1% | 1,206 | $8K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 60 | $7K |
| 92570 | <1% | 253 | $5K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,586 | $5K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 106 | $4K |
| 87428 | <1% | 96 | $4K | |
| 99173 | <1% | 2,851 | $4K | |
| 90648 | <1% | 1,373 | $4K | |
| 90671 | <1% | 409 | $4K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,160 | $4K |
| 86580 | <1% | 586 | $3K | |
| 0004A | <1% | 77 | $3K | |
| 90716 | <1% | 1,358 | $3K | |
| 90686 | <1% | 3,607 | $3K | |
| 90633 | <1% | 1,742 | $3K | |
| 90685 | <1% | 601 | $2K | |
| 90707 | <1% | 1,307 | $2K | |
| 0081A | <1% | 55 | $2K | |
| 90700 | <1% | 576 | $2K | |
| 99381 | <1% | 30 | $2K | |
| 0154A | <1% | 44 | $2K | |
| 90744 | <1% | 1,051 | $2K | |
| 0124A | <1% | 38 | $2K | |
| 90672 | <1% | 855 | $1K | |
| 99496 | <1% | 12 | $1K | |
| 99463 | <1% | 14 | $1K | |
| 0001A | <1% | 34 | $1K | |
| 94060 | <1% | 26 | $1K | |
| 90713 | <1% | 170 | $1K | |
| 0073A | <1% | 25 | $1K | |
| 90723 | <1% | 263 | $750.02 | |
| 90680 | <1% | 2,242 | $714.02 | |
| 0002A | <1% | 19 | $649.57 | |
| 99442 | <1% | 25 | $636.68 | |
| 99051 | <1% | 172 | $603.21 | |
| 0074A | <1% | 15 | $567.44 | |
| 99050 | <1% | 194 | $545.15 | |
| 0003A | <1% | 13 | $537.66 | |
| 90698 | <1% | 1,306 | $410.55 | |
| 90661 | <1% | 130 | $331.65 | |
| 90651 | <1% | 232 | $306.26 | |
| 94664 | <1% | 26 | $275.13 | |
| 99441 | <1% | 21 | $238.14 | |
| 96380 | <1% | 13 | $199.28 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 60 | $88.65 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 15 | $58.58 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 371 | $40.33 |
| 99070 | <1% | 804 | $26.60 | |
| 99001 | <1% | 550 | $17.04 | |
| G9820 | Documentation of a chlamydia screening test with proper follow-up | <1% | 295 | $12.51 |
| 91307 | <1% | 566 | $2.53 | |
| 91308 | <1% | 102 | $0.66 | |
| 91300 | <1% | 213 | $0.64 | |
| 91315 | <1% | 37 | $0.23 | |
| 91312 | <1% | 33 | $0.19 | |
| G9622 | Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | <1% | 1,093 | $0.09 |
| 3008F | <1% | 14,512 | $0.04 | |
| 3016F | 0% | 443 | $0.00 | |
| 3725F | 0% | 444 | $0.00 | |
| 99072 | 0% | 12,894 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 4,556 | $0.00 |
| 90734 | 0% | 53 | $0.00 | |
| 87400 | 0% | 130 | $0.00 | |
| 90715 | 0% | 12 | $0.00 | |
| G9762 | Patient had at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdays | 0% | 30 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 7,479 | $0.00 |
| 90696 | 0% | 196 | $0.00 | |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 421 | $0.00 |
| 1036F | 0% | 442 | $0.00 | |
| 1000F | 0% | 443 | $0.00 | |
| 99000 | 0% | 28 | $0.00 | |
| 90647 | 0% | 54 | $0.00 | |
| 90619 | 0% | 49 | $0.00 | |
| 90660 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.